1. Search Result
Search Result
Results for "

14.18

" in MedChemExpress (MCE) Product Catalog:

29

Inhibitors & Agonists

3

Fluorescent Dye

1

Biochemical Assay Reagents

3

Peptides

3

Inhibitory Antibodies

7

Natural
Products

1

Isotope-Labeled Compounds

2

Antibodies

1

GMP Molecules

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B1418
    Tazobactam
    15+ Cited Publications

    CL-298741; YTR-830H

    Beta-lactamase Antibiotic Bacterial Infection Cancer
    Tazobactam (CL-298741) is a potent β-lactamases inhibitor and penicillin antibiotic. Tazobactam has antibacterial activity. Tazobactam can be used for pneumonia research .
    Tazobactam
  • HY-P1418A

    Thyroid Hormone Receptor Endocrinology
    DPC-AJ1951 TFA, a 14 amino acid peptide that acts as a potent agonist of the parathyroid hormone (PTH)/PTH-related peptide receptor (PPR). And characterized the activity of DPC-AJ1951 TFA in ex vivo and in vivo assays of bone resorption .
    DPC-AJ1951 TFA
  • HY-B1418R

    CL-298741 (Standard); YTR-830H (Standard)

    Beta-lactamase Reference Standards Antibiotic Bacterial Infection
    Tazobactam (Standard) is the analytical standard of Tazobactam. This product is intended for research and analytical applications. Tazobactam (CL-298741) is a potent β-lactamases inhibitor and penicillin antibiotic. Tazobactam has antibacterial activity. Tazobactam can be used for pneumonia research .
    Tazobactam (Standard)
  • HY-N1418

    (-)-Canadine; (S)-(-)-Canadine

    Others Inflammation/Immunology
    (S)-(-)-Tetrahydroberberine is an alkaloid and intermediate in the biosynthesis of berberine with insecticidal activity .
    (S)-(-)-Tetrahydroberberine
  • HY-B1418S2

    CL-298741-15N,d2; YTR-830H-15N,d2

    Isotope-Labeled Compounds Bacterial Antibiotic Beta-lactamase Infection Cancer
    Tazobactam- 15N,d2 (CL-298741- 15N,d2) is 15N and deuterium labeled Tazobactam. Tazobactam (CL-298741) is a potent β-lactamases inhibitor and penicillin antibiotic. Tazobactam has antibacterial activity. Tazobactam can be used for pneumonia research .
    Tazobactam-15N,d2
  • HY-N1418A

    (+)-Canadine; (R)-(+)-Canadine

    Others Inflammation/Immunology
    (R)-(+)-Tetrahydroberberine is the isomer of (S)-(-)-Tetrahydroberberine (HY-N1418), and can be used as an experimental control. (S)-(-)-Tetrahydroberberine is an alkaloid and intermediate in the biosynthesis of berberine with insecticidal activity .
    (R)-(+)-Tetrahydroberberine
  • HY-P1418

    Thyroid Hormone Receptor Endocrinology
    DPC-AJ1951, a 14 amino acid peptide that acts as a potent agonist of the parathyroid hormone (PTH)/PTH-related peptide receptor (PPR). And characterized the activity of DPC-AJ1951 in ex vivo and in vivo assays of bone resorption .
    DPC-AJ1951
  • HY-D1418

    Fluorescent Dye Others
    CP-BP-SFAC is a luminogenic molecule. CP-BP-SFAC exhibits strong sky-blue delayed fluorescence in neat films .
    CP-BP-SFAC
  • HY-16561
    Resveratrol
    Maximum Cited Publications
    160 Publications Verification

    trans-Resveratrol; SRT501

    DNA/RNA Synthesis IKK Autophagy Mitophagy Sirtuin Apoptosis Bacterial Fungal Antibiotic Keap1-Nrf2 Infection Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
    Resveratrol (trans-Resveratrol; SRT501) is a CNS-penetrant natural polyphenolic phytoalexin that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. Resveratrol (SRT 501) has a wide spectrum of targets including mTOR, JAK, β-amyloid, Adenylyl cyclase, IKKβ, DNA polymerase. Resveratrol also is a specific SIRT1 activator . Resveratrol is a potent pregnane X receptor (PXR) inhibitor . Resveratrol is an Nrf2 activator, ameliorates aging-related progressive renal injury in mice model . Resveratrol increases production of NO in endothelial cells .
    Resveratrol
  • HY-125860

    Polyphenol oxidase

    Tyrosinase Neurological Disease Endocrinology Cancer
    Tyrosinase (EC 1.14.18.1) (Polyphenol oxidase) is a rate-limiting enzyme that controls the production of melanin. Tyrosinase is mainly found in melanosomes synthesized by skin melanocytes. Tyrosinase can be used in research on Parkinson's disease, melanoma and pigmentation .
    Tyrosinase, Mushroom
  • HY-P9933

    APN-311; Ch14.18; MAb-14.18

    Apoptosis PERK mTOR Cancer
    Dinutuximab (APN-311) is a chimeric human-mouse anti-GD2 monoclonal antibody. Dinutuximab can bind to GD2 on the cell surface, triggering antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity, and promoting tumor regression. Dinutuximab can inhibit the growth, invasion, and migration and induce apoptosis of tumor cells. Dinutuximab can be used in the research of tumors such as neuroblastoma and breast cancer .
    Dinutuximab
  • HY-16561R
    Resveratrol (Standard)
    Maximum Cited Publications
    160 Publications Verification

    trans-Resveratrol (Standard); SRT501 (Standard)

    Reference Standards IKK Autophagy Mitophagy Sirtuin Apoptosis Bacterial Fungal Antibiotic Keap1-Nrf2 Infection Inflammation/Immunology Cancer
    Resveratrol (Standard) is the analytical standard of Resveratrol. This product is intended for research and analytical applications. Resveratrol (trans-Resveratrol; SRT501), a natural polyphenolic phytoalexin that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. Resveratrol (SRT 501) has a wide spectrum of targets including mTOR, JAK, β-amyloid, Adenylyl cyclase, IKKβ, DNA polymerase. Resveratrol also is a specific SIRT1 activator . Resveratrol is a potent pregnane X receptor (PXR) inhibitor . Resveratrol is an Nrf2 activator, ameliorates aging-related progressive renal injury in mice model . Resveratrol increases production of NO in endothelial cells .
    Resveratrol (Standard)
  • HY-158109

    Antibody-Drug Conjugates (ADCs) CD2 Topoisomerase Cancer
    M3554 is an anti-GD2 antibody-drug conjugate (ADC) based on the humanized anti-GD2 antibody. M3554 consists of the humanized monoclonal antibody hu14.18 (K322A) (HY-P991040) linked to a topoisomerase 1 inhibitor Exatecan (HY-13631) via a cleavable β-glucuronide linker. M3554 can be used for the study of neuroblastoma, osteosarcoma or glioma .
    M3554
  • HY-42849A
    Sultopride hydrochloride
    1 Publications Verification

    LIN-1418 hydrochloride

    Dopamine Receptor Neurological Disease
    Sultopride hydrochloride (LIN-1418 hydrochloride) is a selective antagonist of dopamine D2 receptor.
    Sultopride hydrochloride
  • HY-42849

    LIN-1418

    Dopamine Receptor Neurological Disease
    Sultopride (LIN-1418) is a selective antagonist of dopamine D2 receptor.
    Sultopride
  • HY-D0272

    Estrogen Receptor/ERR Metabolic Disease
    2,3,4-Trihydroxybenzophenone is a hydroxylated benzophenone UV filter with estrogenic activity. 2,3,4-Trihydroxybenzophenone is a quorum sensing inhibitor and an EC 1.14.18.1 (tyrosinase) inhibitor. 2,3,4-Trihydroxybenzophenone is also a human urinary metabolite, a rat metabolite and a drug metabolite .
    2,3,4-Trihydroxybenzophenone
  • HY-16561G

    trans-Resveratrol; SRT501

    DNA/RNA Synthesis IKK Autophagy Mitophagy Sirtuin Apoptosis Bacterial Fungal Keap1-Nrf2 Infection Inflammation/Immunology Cancer
    Resveratrol (GMP) is Resveratrol (HY-16561) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Resveratrol (trans-Resveratrol; SRT501), a natural polyphenolic phytoalexin that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. Resveratrol (SRT 501) has a wide spectrum of targets including mTOR, JAK, β-amyloid, Adenylyl cyclase, IKKβ, DNA polymerase. Resveratrol also is a specific SIRT1 activator . Resveratrol is a potent pregnane X receptor (PXR) inhibitor . Resveratrol is an Nrf2 activator, ameliorates aging-related progressive renal injury in mice model . Resveratrol increases production of NO in endothelial cells .
    Resveratrol
  • HY-115814

    PI3K Inflammation/Immunology
    AM-1430 is an efficient, highly selective and orally active small molecule inhibitor of PI3Kδ with an IC50 of 4.6 nM. AM-1430 exhibits IC50s for PI3Kα, PI3Kβ and PI3Kγ of 14.18, 2.2 and 3.22 μM, respectively. AM-1430 inhibits B cell proliferation and exhibits excellent in vivo activity in pAKT inhibition models and the hemoglobin (KLH) immune response model. AM-1430 can be used for the study of inflammation and autoimmune diseases .
    AM-1430
  • HY-42849AR

    LIN-1418 hydrochloride (Standard)

    Dopamine Receptor Reference Standards Neurological Disease
    Sultopride hydrochloride (Standard) is the analytical standard of Sultopride hydrochloride. This product is intended for research and analytical applications. Sultopride hydrochloride (LIN-1418 hydrochloride) is a selective antagonist of dopamine D2 receptor.
    Sultopride hydrochloride (Standard)
  • HY-154858A

    (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-ol

    Biochemical Assay Reagents Others
    Undecaprenol is a prenol .
    Undecaprenol
  • HY-108405

    Drug Intermediate Others
    Tazobactam impurity 13 is an impurity of Tazobactam (HY-B1418).
    Tazobactam impurity 13
  • HY-B1923A

    Pipracil hydrate

    Antibiotic Bacterial Beta-lactamase Penicillin-binding protein (PBP) Infection Cancer
    Piperacillin hydrate is a semisynthetic broad-spectrum β-lactam antibiotic which exhibits potent bactericidal activity against Gram-negative bacteria as well as select Gram-positive strains through penicillin-binding proteins. Piperacillin hydrate is most commonly used in combination with the β-lactamase inhibitor Tazobactam (HY-B1418) .
    Piperacillin hydrate
  • HY-149632

    EGFR Dihydrofolate reductase (DHFR) Cancer
    EGFR/HER2/DHFR-IN-2 (Compound 4b) is an inhibitor of EGFR, HER2, and DHFR (IC50: 0.248, 0.156, 0.138 μM respectively). EGFR/HER2/DHFR-IN-2 has anticancer activities against a panel of cancer cells (IC50: 9.14, 7.33, 14.18, 24.87, 20.07, 6.16 μM for Hep G2, HeLa, HEp-2, HCT 116, PC-3, MCF7 cells). EGFR/HER2/DHFR-IN-2 reduce breast cancer tumor growth .
    EGFR/HER2/DHFR-IN-2
  • HY-164978

    Kinesin Cancer
    KIF18A-IN-14 (Compound Example 81) is a KIF18A inhibitor. KIF18A-IN-14 is available in two forms, EX81-A and its enantiomer EX81-B. EX81-A and EX81-B inhibit OVCAR-3 cells viability with IC50s of 0-0.01 μM and 0.01-0.1 μM, respectively. KIF18A-IN-14 can be used in tumor (e.g. colon, breast, lung) studies .
    KIF18A-IN-14
  • HY-163601

    HIF/HIF Prolyl-Hydroxylase Cancer
    HIF-2α-IN-14 (18) is a HIF-2α inhibitor, with an IC50 of 0.27 μM .
    HIF-2α-IN-14
  • HY-W585442

    Biochemical Assay Reagents Endogenous Metabolite
    5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine is a photosensitive material with excellent light absorption and electron conduction activity. 5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine is widely used in optoelectronic devices and is considered to be an effective photocatalyst. 5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine can be used to improve the performance of solar cells and increase the photoelectric conversion efficiency. 5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine also has potential anti-tumor activity and can inhibit the proliferation of certain cancer cells. 5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine exhibits excellent fluorescence properties in medical imaging, which helps to improve the clarity and accuracy of imaging. 5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine is studied as a component of a novel compound delivery system to improve the targeting and release effect of the compound.
    5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine
  • HY-W456469

    5,6,7,15,16,17,24,25,26-Nonaazaoctacyclo[9.9.9.0(2,10).0(4,8).0(12,20).0(14,18).0(21,29).0(23,27)]nonacosa-2,4(8),5,9,12,14(18),15,19,21(29),22,24,27-dodecaene

    MOFs Others
    15H-5,11[5′,6′]-Endo-benzotriazoloanthra[2,3-d:6,7-d′]bistriazole, 1,5,7,11-tetrahydro- (5,6,7,15,16,17,24,25,26-Nonaazaoctacyclo[9.9.9.0(2,10).0(4,8).0(12,20).0(14,18).0(21,29).0(23,27)]nonacosa-2,4(8),5,9,12,14(18),15,19,21(29),22,24,27-dodecaene) is a metal-organic framework (MOF).
    15H-5,11[5′,6′]-Endo-benzotriazoloanthra[2,3-d:6,7-d′]bistriazole, 1,5,7,11-tetrahydro-
  • HY-178229

    Antibiotic Bacterial Beta-lactamase Infection
    Piperacillin mixture with tazobactam (8:1) is a compound antibiotic consisting of Piperacillin (HY-B1923) and Tazobactam (HY-B1418), with a ratio of 8:1. Piperacillin mixture with tazobactam (8:1) is a β-lactam/β-lactamase inhibitor combination, with broad-spectrum antibacterial activity, capable of covering most Gram-positive bacteria, Gram-negative aerobic bacteria and anaerobic bacteria, including many pathogens that produce β-lactamase .
    Piperacillin mixture with tazobactam (8:1)
  • HY-P11399

    Bacterial Fungal Infection
    Tachyplesin-3 is a broad-spectrum cationic antimicrobial peptide. Tachyplesin-3 has inhibitory activity against Gram-positive bacteria, Gram-negative bacteria, fungi and enveloped viruses. Tachyplesin-3 binds to bacterial membrane lipopolysaccharides through positive charges, disrupting membrane integrity and causing leakage of cellular contents. Tachyplesin-3 interferes with bacterial adhesion and aggregation, prevents biofilm formation, and has a synergistic effect when used in combination with Piperacillin (HY-B1923) - Tazobactam (HY-B1418) (TZP) .
    Tachyplesin-3

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: